Literature DB >> 28700779

Corneal Wound Repair After Rose Bengal and Green Light Crosslinking: Clinical and Histologic Study.

Patricia Gallego-Muñoz1, Lucía Ibares-Frías1, Elvira Lorenzo1, Susana Marcos2, Pablo Peréz-Merino2, Nandor Bekesi2, Irene E Kochevar3, M Carmen Martínez-García1.   

Abstract

Purpose: To evaluate corneal wound healing after treatment with a new collagen crosslinking protocol using rose bengal dye and green light (RGX).
Methods: One cornea of 20 New Zealand rabbits was de-epithelialized (DE) in an 8-mm diameter circle and, in another group (n = 25), the DE corneas were then stained with 0.1% rose bengal for 2 minutes and exposed to green light (532 nm) for 7 minutes (RGX). The contralateral eyes without treatment acted as controls. The animals were clinically followed including fluorescein staining and pachymetry. Healing events were analyzed after euthanasia at 2, 30, and 60 days. Cell death (TUNEL assay), cell proliferation (5-bromo-2'-deoxyuridine incorporation), and cell differentiation to myofibroblasts (α-SMA labeling) were carried out. In addition, loss of keratocytes and subsequent repopulation of the corneal stroma were quantified on hematoxylin-eosin-stained sections.
Results: Wound closure was slower after RGX (4.4 days) then after DE (3.3 days). Cell death was restricted to the anterior central stroma, and the cellular decrease did not differ significantly between RGX and DE corneas. Cell proliferation in the epithelium and stroma appeared at 2 days. In both DE and RGX corneas, recovery of the epithelium was complete at day 30, although cell repopulation of the stroma was not complete at 60 days. Conclusions: The healing response in corneas after RGX is very similar to that observed after DE alone, suggesting that, along with its short treatment time and limited effect on keratocytes, RGX displays good potential for clinical cornea stiffening.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28700779     DOI: 10.1167/iovs.16-21365

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Rose bengal photodynamic antimicrobial therapy to inhibit Pseudomonas aeruginosa keratitis isolates.

Authors:  Heather Durkee; Alejandro Arboleda; Mariela C Aguilar; Jaime D Martinez; Karam A Alawa; Nidhi Relhan; Jorge Maestre-Mesa; Guillermo Amescua; Darlene Miller; Jean-Marie Parel
Journal:  Lasers Med Sci       Date:  2019-12-23       Impact factor: 3.161

2.  Human Corneal Changes After Rose Bengal Photodynamic Antimicrobial Therapy for Treatment of Fungal Keratitis.

Authors:  Jaime D Martinez; Andrea Naranjo; Guillermo Amescua; Sander R Dubovy; Alejandro Arboleda; Heather Durkee; Mariela C Aguilar; Harry W Flynn; Darlene Miller; Jean-Marie Parel
Journal:  Cornea       Date:  2018-10       Impact factor: 2.651

3.  Rose Bengal-Mediated Photoinactivation of Multidrug Resistant Pseudomonas aeruginosa Is Enhanced in the Presence of Antimicrobial Peptides.

Authors:  Joanna Nakonieczna; Katarzyna Wolnikowska; Patrycja Ogonowska; Damian Neubauer; Agnieszka Bernat; Wojciech Kamysz
Journal:  Front Microbiol       Date:  2018-08-20       Impact factor: 5.640

4.  Rose Bengal Photodynamic Antimicrobial Therapy: A Pilot Safety Study.

Authors:  Jaime D Martinez; Esdras Arrieta; Andrea Naranjo; Pedro Monsalve; Keenan J Mintz; Jeffrey Peterson; Alejandro Arboleda; Heather Durkee; Mariela C Aguilar; Daniel Pelaez; Sander R Dubovy; Darlene Miller; Roger Leblanc; Guillermo Amescua; Jean-Marie Parel
Journal:  Cornea       Date:  2021-08-01       Impact factor: 3.152

5.  Arginine as an Enhancer in Rose Bengal Photosensitized Corneal Crosslinking.

Authors:  Christian M Wertheimer; Bryan Mendes; Qing Pei; Katharina Brandt; Irene E Kochevar
Journal:  Transl Vis Sci Technol       Date:  2020-07-14       Impact factor: 3.283

6.  Rose Bengal Crosslinking to Stabilize Collagen Sheets and Generate Modulated Collagen Laminates.

Authors:  Stefanie Eckes; Joy Braun; Julia S Wack; Ulrike Ritz; Daniela Nickel; Katja Schmitz
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.